Overall drug treatment of idiopathic pulmonary fibrosis patients from national registries – a real-world study from Finland

BACKGROUND: Currently, two disease-modifying antifibrotic drugs are indicated for the treatment of idiopathic pulmonary fibrosis. The objective of this study was to analyse antifibrotic and overall prescription medication use of IPF patients in the real world. METHODS: Data was collected from the Fi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaunisto, Jaana, Salomaa, Eija-Riitta, Koivisto, Mari, Myllärniemi, Marjukka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10543307/
https://www.ncbi.nlm.nih.gov/pubmed/37777734
http://dx.doi.org/10.1186/s12890-023-02630-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10543307/
https://www.ncbi.nlm.nih.gov/pubmed/37777734
http://dx.doi.org/10.1186/s12890-023-02630-1

Ejemplares similares